Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study | Zendy

Eloísa Riva | Zendy; Patricio Duarte | Zendy; Bryan Valcárcel | Zendy; Guillermina Remaggi | Zendy; Iván Murrieta-Álvarez | Zendy; Ariel Corzo | Zendy; Daniel Del Carpio-Jayo | Zendy; Camila Peña | Zendy; Jule F Vasquez | Zendy; Virginia Bove | Zendy; Larissa Lane Cardoso Teixeira | Zendy; Guilherme Fleury-Perini | Zendy; Sebastián Yantorno | Zendy; César Samanez-Figari | Zendy; Sergio Lopresti | Zendy; Milagros Altamirano-Molina | Zendy; Luís Villela | Zendy; Guillermo J. RuízArgüelles | Zendy; Guillermo J. RuizDelgado | Zendy; Efréen Montaño | Zendy; Verónica Verri | Zendy; Elia Zamora Pérez | Zendy; Fernando PérezJacobo | Zendy; Henry Idrobo | Zendy; Humberto MartínezCordero | Zendy; Brady Beltrán | Zendy; Jhoanna Ramírez | Zendy; Jorge J. Castillo | Zendy; Luis Malpica | Zendy

Open Access

Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study

Author(s) -

Eloísa Riva,

Patricio Duarte,

Bryan Valcárcel,

Guillermina Remaggi,

Iván Murrieta-Álvarez,

Ariel Corzo,

Daniel Del Carpio-Jayo,

Camila Peña,

Jule F Vasquez,

Virginia Bove,

Larissa Lane Cardoso Teixeira,

Guilherme Fleury-Perini,

Sebastián Yantorno,

César Samanez-Figari,

Sergio Lopresti,

Milagros Altamirano-Molina,

Luís Villela,

Guillermo J. RuízArgüelles,

Guillermo J. RuizDelgado,

Efréen Montaño,

Verónica Verri,

Elia Zamora Pérez,

Fernando PérezJacobo,

Henry Idrobo,

Humberto MartínezCordero,

Brady Beltrán,

Jhoanna Ramírez,

Jorge J. Castillo,

Luis Malpica

Publication year - 2022

Publication title -

jco global oncology

Language(s) - English

Resource type - Journals

ISSN - 2687-8941

DOI - 10.1200/go.21.00380

Subject(s) - medicine , chemoimmunotherapy , waldenstrom macroglobulinemia , hazard ratio , macroglobulinemia , retrospective cohort study , proportional hazards model , cohort , oncology , lymphoma , rituximab , confidence interval , multiple myeloma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research